Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Dec 04, 2020 12:39pm
80 Views
Post# 32037735

RE:7.2 Million

RE:7.2 MillionLast offering when we got the Minimum they were planning to hire 3 people and instead hired 12 which was more than the 9 the planned if they had even got the Maximum, it'll be fun to see what comes now with 7.2:)



Newfinvest wrote: Is what was raised. Now that we have this info I would like to see the new plan of how the money will be allocated. Where will the focus be for the spending now that we are at 72% of the full subscription. The focus needs to remain spending and marketing for Aristotle prep and roll out. What dollar figure will be assigned to that. It stood they actually released the report on Dec 4 as previously stated... I will acknowledge and note it is appreciated they met their set deadlines. I will reserve celebration for news on Aristotle. Im not trading... im investing... my investment is based on Aristotle and its potential.


<< Previous
Bullboard Posts
Next >>